WallStreetZenWallStreetZen

NASDAQ: AKTS
Aktis Oncology Inc Stock Ownership - Who owns Aktis Oncology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aktis Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Akos CzibereChief Medical Officer2026-07-084,371$28.71
$125.48kSell
Akos CzibereChief Medical Officer2026-07-0814,800$27.13
$401.48kSell
Shulamit RonbiggerChief Operating Officer2026-07-0850,000$3.66
$183.00kBuy
Shulamit RonbiggerChief Operating Officer2026-07-0815,800$27.13
$428.69kSell
Shulamit RonbiggerChief Operating Officer2026-07-0830,000$27.94
$838.14kSell
Shulamit RonbiggerChief Operating Officer2026-07-084,200$28.75
$120.74kSell
Akos CzibereChief Medical Officer2026-07-0830,829$27.95
$861.73kSell
Akos CzibereChief Medical Officer2026-07-0850,000$4.95
$247.50kBuy
Vida Ventures II LLC10% Owner2026-01-12812,455$18.00
$14.62MBuy
Vida Ventures II LLC10% Owner2026-01-1222,545$18.00
$405.81kBuy

1 of 2

AKTS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKTS insiders and whales buy or sell their stock.

AKTS Shareholders

What type of owners hold Aktis Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ansbert Gadicke19.21%10,260,064$286.05MInsider
Mpm Bioventures 2018 LP19.21%10,260,064$286.05MInsider
Lilly Co Eli11.88%6,344,114$176.87MInsider
Mpm Bioimpact LLC9.06%4,835,872$134.82MInstitution
Ecor1 Capital LLC9.03%4,824,469$134.51MInstitution
Todd Foley7.93%4,235,403$118.08MInsider
Blue Owl Capital Holdings LP5.92%3,161,348$88.14MInstitution
Wellington Management Group LLP4.34%2,317,044$64.60MInstitution
T Rowe Price Investment Management Inc3.98%2,123,812$59.21MInstitution
Blackrock Inc3.95%2,112,127$58.89MInstitution

1 of 3

AKTS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKTS52.35%47.65%Net BuyingNet Buying
MLTX79.65%20.35%Net SellingNet Selling
NVAX71.75%17.19%Net Selling
XERS60.94%14.25%Net SellingNet Selling
AVBP80.88%19.12%Net Selling
View Top Biotech Stocks

Aktis Oncology Stock Ownership FAQ

Who owns Aktis Oncology?

Aktis Oncology (NASDAQ: AKTS) is owned by 65.88% institutional shareholders, 59.95% Aktis Oncology insiders, and 0.00% retail investors. Ansbert Gadicke is the largest individual Aktis Oncology shareholder, owning 10.26M shares representing 19.21% of the company. Ansbert Gadicke's Aktis Oncology shares are currently valued at $286.05M.

If you're new to stock investing, here's how to buy Aktis Oncology stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.